Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies.

Clicks: 368
ID: 4990
2011
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #45 of 161 articles by views in Lancet (London, England)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 161 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
We tested whether genetic factors distinctly contribute to either development of coronary atherosclerosis or, specifically, to myocardial infarction in existing coronary atherosclerosis.We did two genome-wide association studies (GWAS) with coronary angiographic phenotyping in participants of European ancestry. To identify loci that predispose to angiographic coronary artery disease (CAD), we compared individuals who had this disorder (n=12,393) with those who did not (controls, n=7383). To identify loci that predispose to myocardial infarction, we compared patients who had angiographic CAD and myocardial infarction (n=5783) with those who had angiographic CAD but no myocardial infarction (n=3644).In the comparison of patients with angiographic CAD versus controls, we identified a novel locus, ADAMTS7 (p=4·98×10(-13)). In the comparison of patients with angiographic CAD who had myocardial infarction versus those with angiographic CAD but no myocardial infarction, we identified a novel association at the ABO locus (p=7·62×10(-9)). The ABO association was attributable to the glycotransferase-deficient enzyme that encodes the ABO blood group O phenotype previously proposed to protect against myocardial infarction.Our findings indicate that specific genetic predispositions promote the development of coronary atherosclerosis whereas others lead to myocardial infarction in the presence of coronary atherosclerosis. The relation to specific CAD phenotypes might modify how novel loci are applied in personalised risk assessment and used in the development of novel therapies for CAD.The PennCath and MedStar studies were supported by the Cardiovascular Institute of the University of Pennsylvania, by the MedStar Health Research Institute at Washington Hospital Center and by a research grant from GlaxoSmithKline. The funding and support for the other cohorts contributing to the paper are described in the webappendix.
Reference Key
reilly2011identificationlancet Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Reilly, Muredach P;Li, Mingyao;He, Jing;Ferguson, Jane F;Stylianou, Ioannis M;Mehta, Nehal N;Burnett, Mary Susan;Devaney, Joseph M;Knouff, Christopher W;Thompson, John R;Horne, Benjamin D;Stewart, Alexandre F R;Assimes, Themistocles L;Wild, Philipp S;Allayee, Hooman;Nitschke, Patrick Linsel;Patel, Riyaz S;, ;, ;Martinelli, Nicola;Girelli, Domenico;Quyyumi, Arshed A;Anderson, Jeffrey L;Erdmann, Jeanette;Hall, Alistair S;Schunkert, Heribert;Quertermous, Thomas;Blankenberg, Stefan;Hazen, Stanley L;Roberts, Robert;Kathiresan, Sekar;Samani, Nilesh J;Epstein, Stephen E;Rader, Daniel J;
Journal Lancet (London, England)
Year 2011
DOI
10.1016/S0140-6736(10)61996-4
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.